Literature DB >> 24192125

Pregnancy and pharmacogenomics in the context of drug metabolism and response.

Anders Helldén1, Parvaz Madadi.   

Abstract

It is well-known that profound physiological and biochemical changes occur throughout the course of pregnancy. At the same time, the role of pharmacogenomics in modulating the metabolism and response profile to numerous medications has been elucidated. Yet, the clinical impact of pharmacogenomics during pregnancy is less well understood. We present an overview of factors modulating the pharmacokinetics and pharmacodynamics of medications throughout the time span of pregnancy while providing insights on how pharmacogenomics may contribute to interindividual variability in drug metabolism and response amongst pregnant women.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24192125     DOI: 10.2217/pgs.13.176

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  7 in total

1.  Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.

Authors:  Anna H Tran; Brookie M Best; Alice Stek; Jiajia Wang; Edmund V Capparelli; Sandra K Burchett; Regis Kreitchmann; Kittipong Rungruengthanakit; Kathleen George; Tim R Cressey; Nahida Chakhtoura; Elizabeth Smith; David E Shapiro; Mark Mirochnick
Journal:  J Acquir Immune Defic Syndr       Date:  2016-07-01       Impact factor: 3.731

Review 2.  The brain-placental axis: Therapeutic and pharmacological relevancy to pregnancy.

Authors:  Susanta K Behura; Pramod Dhakal; Andrew M Kelleher; Ahmed Balboula; Amanda Patterson; Thomas E Spencer
Journal:  Pharmacol Res       Date:  2019-10-07       Impact factor: 7.658

Review 3.  Epidemiology of medications use in pregnancy.

Authors:  Martina Ayad; Maged M Costantine
Journal:  Semin Perinatol       Date:  2015-09-08       Impact factor: 3.300

4.  Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development.

Authors:  John V Ilekis; Ekaterini Tsilou; Susan Fisher; Vikki M Abrahams; Michael J Soares; James C Cross; Stacy Zamudio; Nicholas P Illsley; Leslie Myatt; Christine Colvis; Maged M Costantine; David M Haas; Yoel Sadovsky; Carl Weiner; Erik Rytting; Gene Bidwell
Journal:  Am J Obstet Gynecol       Date:  2016-03-10       Impact factor: 8.661

5.  Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy.

Authors:  Lyrialle W Han; Lu Wang; Yuanyuan Shi; Joseph L Dempsey; Olesya V Pershutkina; Moumita Dutta; Theo K Bammler; Julia Y Cui; Qingcheng Mao
Journal:  Drug Metab Dispos       Date:  2020-06-04       Impact factor: 3.922

6.  Malaria prevalence, severity and treatment outcome in relation to day 7 lumefantrine plasma concentration in pregnant women.

Authors:  Ritah F Mutagonda; Appolinary A R Kamuhabwa; Omary M S Minzi; Siriel N Massawe; Betty A Maganda; Eleni Aklillu
Journal:  Malar J       Date:  2016-05-13       Impact factor: 2.979

7.  MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero.

Authors:  Essi Heinonen; Barbara Szymanska-von Schultz; Viktor Kaldo; Josefine Nasiell; Ewa Andersson; Mikaela Bergmark; Margareta Blomdahl-Wetterholm; Lisa Forsberg; Erik Forsell; Anna Forsgren; Sandra Frööjd; Amy Goldman; Eva-Mari Nordenadler; Myrto Sklivanioti; Mats Blennow; Katarina Wide; Lars L Gustafsson
Journal:  BMJ Open       Date:  2018-08-05       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.